Rational antithrombotic use in an atrial fibrillation population.

01 October 2019 → 01 November 2019
Regional and community funding: Special Research Fund
Research disciplines
  • Medical and health sciences
    • Public health sciences not elsewhere classified
    • Pharmacology not elsewhere classified
    • Pharmacotherapy not elsewhere classified
Non-vitamin K oral anticoagulants (NOACs) Atrial fibrillation Stroke prevention Bleeding complications Pharmacoepidemiology Therapy adherence Polypharmacy Multimorbidity Pharmacogenetics
Project description

The aim of my project is to study rational antithrombotic use in terms of effectiveness and safety in a real-life population with atrial fibrillation. By studying the use and impact of antithrombotics in clinical practice, we want to unravel determinants of treatment success in terms of prevention of thromboembolisms and bleeding complications in a general population with multimorbidity and polypharmacy.